-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL - ANNOUNCES EMA VALIDATION OF MAA FOR REBISUFLIGENE ETISPARVOVEC GENE THERAPY

Reuters·10/02/2026 06:03:32

Please log in to view news